01/2025

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

01/2025

Jan 13, 2025, 20:21 | Insight
Navneet Singh: Expert consensus statement on the peri-operative management of NSCLC
Navneet Singh, Thoracic Medical Oncologist at the Postgraduate Institute of Medical Education and Research, shared…
Jan 13, 2025, 19:46 | Blog
Michael Pignone is a keynote speaker of Ca-PRI 2025 - Manchester Cancer Research Centre
Manchester Cancer Research Centre shared a post on LinkedIn: "Keynote speaker announced for Ca-PRI 2025!…
Jan 13, 2025, 19:44 | Blog
SABCS 2024 highlights breakthrough therapies in breast cancer care - AACR
American Association for Cancer Research shared a post on LinkedIn: "The 2024 San Antonio Breast…
Jan 13, 2025, 19:41 | Blog
Professor Gianluca Franceschini: Advancing Breast Cancer Surgery - Mediamedic
Mediamedic shared a post on LinkedIn: "Professor Gianluca Franceschini: Advancing Breast Cancer Surgery. We are…
Jan 13, 2025, 19:39 | Blog
Helping people in the path of natural disasters to continue their cancer care - NCI Division of Cancer Prevention
NCI Division of Cancer Prevention shared a post on LinkedIn: "People in the path of…
Jan 13, 2025, 19:36 | Blog
The Part V of the North America Series - AORTIC Africa
AORTIC Africa shared a post on LinkedIn: "The next Part V of the North America…
Jan 13, 2025, 19:30 | Insight
Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline
A recent paper by Evan Yu, Professor at the University of Washington, was mentioned by…
Jan 13, 2025, 19:28 | Blog
Amol Akhade: Does anyone have any data on post-progression therapy of the control arm of the Adriatic trial?
Amol Akhade, Senior Consultant Medical Oncologist and Hemato-oncologist at Suyog Cancer Clinics and Reliance Hospitals,…
Jan 13, 2025, 17:57 | Blog
Anirban Maitra: Is there a functionally consequential intratumoral microbiome in pancreatic cancer or not?
Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center,…
Jan 13, 2025, 17:54 | Oncolibrary
NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results
Title: Efficacy outcomes of CDK4/6 inhibitors in combination with endocrine therapy treatment in hormone receptor-positive/HER2-negative…
All: 2689 Posts: 1771 - 1780
Special Coverage